Stoxline.com
android_stock_chart
Stock Chart

Stoxline Lite

Stoxline Pro

Option Calculator
Stoxline
Mobile

Home | Charts | Showcases | Stock Ranks | Options | ETFs | Educations

 

7 Binary Options

 

Enter Stock Symbol:  

Aurinia Pharm Ord (AUPH)

6.10 -0.01 (-0.16%)

8/18/2017  4:00pm

Open:

6.10

Pre. Close:

6.11

High:

6.19

Low:

6.01

Volume:

579,843

Market Cap:

509.26M

Stock Price Prediction (Update at 5:00pm est.)

If tomorrow:

Open lower

Open higher

High:

6.32 - 6.34

6.34 - 6.35

Low:

5.83 - 5.87

5.87 - 5.9

Close:

6.04 - 6.14

6.14 - 6.2

Technical analysis  (as of: 2017-08-18 4:35:09 PM)

Overall:

      

Stoxline posted a NEUTRAL today, same as yesterday. This stock seems to stay at current move trend, but it could change at anytime. So it is not a good time to buy or sell, stay at where you are until next Buy or SELL signal.

Target:

Six months: 8.07     One year: 8.97

Support:

Support1: 5.66    Support2: 4.71

Resistance:

Resistance1: 6.91    Resistance2: 7.68

Pivot:

6.10

Moving Averages:

MA(5): 6.16     MA(20): 6.18

MA(100): 6.61     MA(250): 4.76

MACD:

MACD(12,26): -0.08     Signal(12,26,9): -0.09

%K %D:

%K(14,3): 59.88     %D(3): 58.05

RSI:

RSI(14): 46.28

52-Week:

High: 10.54  Low: 1.88  Change(%): 181.1

Average Vol(K):

3-Month: 154588  10-Days 42229

Strong Sell ★★ Sell ★★★ Neutral ★★★★ Buy ★★★★★ Strong Buy

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.
AUPH has closed below upper band by 49.4%. Bollinger Bands are 50.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to AUPH's normal range. The bands have been in this narrow range for 2 bars. This is a sign that the market may be about to initiate a new trend.

Headline News

Tue, 28 Mar 2017 13:34:19 GMT
Aurinia Pharmaceuticals: Highlighting An Important Clinical And Regulatory Change

Tue, 14 Mar 2017 20:03:45 GMT
Aurinia Pharmaceuticals: All Systems Go

Fri, 24 Mar 2017 13:53:27 GMT
Aurinia Pharmaceuticals: Fully Funded With Upcoming Catalysts

Mon, 01 May 2017 13:57:07 GMT
Aurinia Pharmaceuticals Is A Top Pick For H2 2017

Mon, 06 Mar 2017 22:41:15 GMT
Why Is Aurinia Pharmaceuticals A Definite Buy In 2017?

Financial Analysis

Growth

NA

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.

Profitability

NA

Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.

Solvency

NA

Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.

Efficiency

NA

Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.

Click here to get more fundamental analysis.

 

Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare

Industry:  Bio Therapeutic Drugs

Shares Out. (M)

82.10

Shares Float (M)

44.87

% Held by Insiders

% Held by Institutions

Shares Short (K)

11380

Shares Short Prior Month (K)

11870

Stock Financials

EPS

-1.720

EPS Est. Current Year

-0.740

EPS Est. Next Year

-0.550

EPS Est. Next Quarter

-0.130

Forward EPS

-0.550

Book Value (p.s.)

2.100

PEG Ratio

Profit Margin

Operating Margin

-19021.09

Return on Assets (ttm)

-14.1

Return on Equity (ttm)

-75.2

Qtrly Rev. Growth

-45.6

Gross Profit (p.s.)

0.002

Sales Per Share

EBITDA (p.s.)

-0.323

Qtrly Earnings Growth

Operating Cash Flow (M)

-23.21

Levered Free Cash Flow (M)

-10.21

FoxReading.com

Valuation

P/E

-3.55

P/E Growth Ratio

P/BV

2.90

P/S

P/CF

-21.58

Dividend Yield

Dividends & Splits

Dividend

Dividend Pay Date

Invalid DateTime.

Ex-Dividend Date

Invalid DateTime.

Forward Dividend

Last Split Date

Last Split Ratio

-1e+010

 

(c) 2006-2017 Stoxline.com | Contact us | NYSE, NASDAQ, AMEX Stock symbols

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.